Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE905.157.9 (+0.88 %)
PREV CLOSE ( ) 897.25
OPEN PRICE ( ) 899.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 27211
TODAY'S LOW / HIGH ( )882.00 907.80
52 WK LOW / HIGH ( )450 995.05
NSE905.108.35 (+0.93 %)
PREV CLOSE( ) 896.75
OPEN PRICE ( ) 903.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 905.10 (16)
VOLUME 164070
TODAY'S LOW / HIGH( ) 882.95 907.20
52 WK LOW / HIGH ( )402.55 996
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

04Jan Announcement under Regulation 30 (LOD
Allotment of 46,795 Equity shares of Rs.2/- each ESOP under NATSOP2016 s..
18Dec Natco Pharma gains on launching anti b
Natco Pharma is currently trading at Rs. 943.80, up by 2.15 points or 0...
17Dec Natco Pharma launches anti blood clot
Natco Pharma has launched Rivaroxaban molecule, under brand RPIGAT. Riva..
17Dec NATCO Pharma informs about press release
NATCO Pharma has informed that it has enclosed the Press Release on 17th..
17Dec Announcement under Regulation 30 (LOD
NATCO launches anti blood clot tablet Rivaroxaban in India

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit7094745
Gross Profit 865 5831
Operating Profit 11767018
Net Sales 478917902

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Gland Pharma (BSE)
peergroup  2282.90 (3.53%)
M.Cap ( in Cr)37275.84
Solara Active Pharma (BSE)
peergroup  1344.25 (4.17%)
M.Cap ( in Cr)4827.17
RPG Life Sciences (BSE)
peergroup  444.50 (6.54%)
M.Cap ( in Cr)735.16
Aurobindo Pharma (BSE)
peergroup  923.65 (2.33%)
M.Cap ( in Cr)54120.22
Orchid Pharma (BSE)
peergroup  274.80 (4.99%)
M.Cap ( in Cr)1121.63

Shareholding Pattern

MUTUAL FUNDS/UTI 8.92%
PROMOTERS 48.91%
FII 18.17%
NON-INSTITUTION 17.88%
FI/BANKS/INSURANCE 0.19%
GOVERNMENT 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 905.15. Its current market capitalisation stands at Rs 16494.83 Cr. In the latest quarter, company has reported Gross Sales of Rs. 18884 Cr and Total Income of Rs.19140 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, PSRK Prasad, Rajeev Nannapaneni, MUR Naidu, Leela Digumarti, DG Prasad, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)